Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy) Academic Article uri icon

Overview

MeSH Major

  • Aortic Valve
  • Atenolol
  • Heart Valve Diseases
  • Losartan

abstract

  • Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

publication date

  • October 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.amjcard.2004.06.074

PubMed ID

  • 15476632

Additional Document Info

start page

  • 1076

end page

  • 80

volume

  • 94

number

  • 8